找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Oncolytic Viruses; Christine E. Engeland Book 2020 Springer Science+Business Media, LLC, part of Springer Nature 2020 Virotherapy.Vector D

[复制链接]
楼主: deflate
发表于 2025-3-28 17:03:30 | 显示全部楼层
A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell induce an antitumor immune response. Here, we describe a method to determine if an OV is able to induce such an immunogenic tumor cell death. This method consists in testing whether tumor cells lysed by an OV are able to induce the maturation of human monocyte-derived immature dendritic cells (Mo-iD
发表于 2025-3-28 18:48:19 | 显示全部楼层
Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation,important pathogen in the poultry industry. The establishment of a reverse genetics system for this virus has enabled the development of genetically modified recombinant NDV viruses with improved oncolytic and immunotherapeutic properties. In this chapter, we describe the materials and methods invol
发表于 2025-3-29 00:26:39 | 显示全部楼层
Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue,o their immune-stimulatory effects. The shifting focus on virus-mediated immune modulation calls for a comprehensive analysis of the tumor microenvironment (TME) and the factors orchestrating the antiviral and antitumor immune response. The oncolytic VSV-GP studied in our lab is a safe and potent an
发表于 2025-3-29 05:54:30 | 显示全部楼层
发表于 2025-3-29 10:26:55 | 显示全部楼层
发表于 2025-3-29 15:29:22 | 显示全部楼层
Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models,that immunostimulatory properties of oncolytic viruses (OVs) are crucial for their therapeutic efficacy. The specific lysis of tumor cells and release of tumor associated antigens in the context of an OV infection ensures activation of a tumor-specific immune response. The evidence for induction of
发表于 2025-3-29 18:54:12 | 显示全部楼层
Delivery of Oncolytic Reovirus by Cell Carriers,tment options. However, as single agents oncolytic viruses have shown only moderate clinical benefit and many challenges remain before their full potential is realized. Central to this is the efficient delivery of the virus to the tumor site and potentiation of the antitumor immune response. This ch
发表于 2025-3-29 22:10:51 | 显示全部楼层
发表于 2025-3-30 02:38:14 | 显示全部楼层
发表于 2025-3-30 05:57:38 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-17 17:53
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表